RxDoctor Payments Data

Paul Manoukian

Otolaryngology · Carson City, NVNPI 1083673909

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,800 of the $6,755 with a category attached, or 71.1%. Medical Device Business Services, Inc. accounts for 65.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $5,016 and has fallen 87.4% since, to $631 in 2025.

$6,755in general payments, 2019–2025

Across 49 payments — averaging $137.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$4K
  • Acclarent, Inc$887
  • Regeneron Healthcare Solutions, Inc.$372
  • Aerin Medical Inc.$352
  • Medtronic$189
  • Regeneron$107
  • plus $417 from 9 others

What the payments were for

  • Consulting fees$4,80071%
  • Food & beverage$1,86628%
  • Education$891%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,755 in reported general payments places this provider in the 85th percentile of 41 otolaryngology providers in Nevada.

See all otolaryngology providers in Nevada

Medicare billing

Part B allowed, 2024
$231,541
Medicare patients
788
Services billed
2,178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide155$7,708
Fluticasone Propionate226$3,583
Montelukast Sodium52$856
Omeprazole62$650
Ofloxacin15$556
Azelastine Hcl18$490
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen50$458
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$311
Clindamycin Hcl16$200
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid13$118
Amoxicillin11$53
Levothyroxine Sodium16$41

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Carson City

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →